Renhe Pharmacy Co.,Ltd (SHE:000650)

China · Delayed Price · Currency is CNY

5.47

+0.08 (1.48%)

Jul 29, 2026, 3:04 PM CST

-6.34% (1Y)

Market Cap	7.57B -5.9%
Revenue (ttm)	3.68B -3.7%
Net Income	369.28M -21.3%
EPS	0.26 -21.8%
Shares Out	1.38B
PE Ratio	20.80
Forward PE	n/a
Dividend	0.15 (2.78%)
Ex-Dividend Date	Jul 17, 2026

Volume	16,764,200
Open	5.39
Previous Close	5.39
Day's Range	5.37 - 5.49
52-Week Range	4.85 - 7.02
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. The company offers Chinese and western medicines; and APIs and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, external lotions, liniments, suppositories, ointments and other dosage forms of medicines, as well as health-related products. It also provides chemical raw materials and preparations; Chinese medicinal herbs; processed Chinese medicinal herbs; prepared Chinese medicines; antibiotics... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1996

Employees 4,923

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000650

Full Company Profile

Financial Performance

In 2025, Renhe Pharmacy Co.,Ltd's revenue was 3.54 billion, a decrease of -13.21% compared to the previous year's 4.07 billion. Earnings were 393.21 million, a decrease of -18.41%.

Financial Statements